Oncoclínicas Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 2,137

Employees

  • Stock Symbol
  • ONCO3

Stock Symbol

  • Investments
  • 24

  • Share Price
  • $0.14
  • (As of Friday Closing)

Oncoclínicas General Information

Description

Oncoclinicas Do Brasil Servicos Medicos SA is engaged in the management and administration of oncological services. It has specialists in the areas of oncology, radiotherapy, hematology, and bone marrow transplantation, complementary care. The Group operates solely in the healthcare services segment, with an emphasis on oncology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Avenida Presidente Juscelino Kubitschek
  • Nº 510, 2nd floor, Vila Nova Conceição
  • Sao Paulo, 04543-906
  • Brazil
+55 (11)
Primary Industry
Hospitals/Inpatient Services
Other Industries
Clinics/Outpatient Services
Stock Exchange
BVMF
Vertical(s)
Corporate Office
  • Avenida Presidente Juscelino Kubitschek
  • Nº 510, 2nd floor, Vila Nova Conceição
  • Sao Paulo, 04543-906
  • Brazil
+55 (11)

Oncoclínicas Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncoclínicas Stock Performance

As of 13-Nov-2026, Oncoclínicas’s stock price is $0.14. Its current market cap is $162M with 1.13B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.14 $0.16 $0.10 - $0.58 $162M 1.13B 17.3M -$0.97

Oncoclínicas Financials Summary

As of 30-Jun-2026, Oncoclínicas has a trailing 12-month revenue of $942M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,000,905 1,372,149 883,137 2,084,407
Revenue 942,185 1,025,491 1,155,658 1,098,159
EBITDA (571,851) (400,610) 42,045 219,369
Net Income (798,657) (647,487) (119,921) 44,740
Total Assets 1,272,280 1,301,379 1,812,411 1,891,773
Total Debt 735,327 693,316 886,343 938,654
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Oncoclínicas Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oncoclínicas‘s full profile, request access.

Request a free trial

Oncoclínicas Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncoclínicas Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oncoclínicas‘s full profile, request access.

Request a free trial

Oncoclínicas Investments & Acquisitions (24)

Oncoclínicas’s most recent deal was a Merger/Acquisition with Cettro. The deal was made on 01-Feb-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cettro 01-Feb-2025 Merger/Acquisition Hospitals/Inpatient Services
Joint Venture (Oncoclínicas / Al Faisaliah Group) 06-Aug-2024 Joint Venture Clinics/Outpatient Services
Joint Venture (Oncological Medical Services) 07-Jun-2023 Joint Venture Clinics/Outpatient Services
Centro De Excelência Oncológica 18-May-2023 Buyout/LBO Clinics/Outpatient Services
Cardiomobile Cardiomovel 07-Feb-2023 Buyout/LBO Clinics/Outpatient Services
You’re viewing 5 of 24 investments and acquisitions. Get the full list »

Oncoclínicas ESG

Risk Overview

Risk Rating

Updated December, 31, 2023

25.16 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,766

Rank

Percentile

Healthcare

Industry

of 581

Rank

Percentile

Medical Services

Subindustry

of 100

Rank

Percentile

To view Oncoclínicas’s complete esg history, request access »

Oncoclínicas Exits (2)

Oncoclínicas’s most recent exit was on 21-Mar-2022 from Medsir. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Medsir 21-Mar-2022 Completed
Hospital Marcos Moraes 19-Aug-2020 Merger/Acquisition Completed
  • 2 buyers
To view Oncoclínicas’s complete exits history, request access »

Oncoclínicas Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Boston Lighthouse Innovations Cambridge, MA 2017
Hospital Vila da Serra Nova Lima, Brazil 1999
Cemise Aracaju, Brazil 1988
Unidade de Oncologia Clínica e Pediátrica Sao Paulo, Brazil 1987

Oncoclínicas FAQs

  • When was Oncoclínicas founded?

    Oncoclínicas was founded in 2010.

  • Where is Oncoclínicas headquartered?

    Oncoclínicas is headquartered in Sao Paulo, Brazil.

  • What is the size of Oncoclínicas?

    Oncoclínicas has 2,137 total employees.

  • What industry is Oncoclínicas in?

    Oncoclínicas’s primary industry is Hospitals/Inpatient Services.

  • Is Oncoclínicas a private or public company?

    Oncoclínicas is a Public company.

  • What is Oncoclínicas’s stock symbol?

    The ticker symbol for Oncoclínicas is ONCO3.

  • What is the current stock price of Oncoclínicas?

    As of 13-Nov-2026 the stock price of Oncoclínicas is $0.14.

  • What is the current market cap of Oncoclínicas?

    The current market capitalization of Oncoclínicas is $162M.

  • What is Oncoclínicas’s current revenue?

    The trailing twelve month revenue for Oncoclínicas is $942M.

  • What is Oncoclínicas’s annual earnings per share (EPS)?

    Oncoclínicas’s EPS for 12 months was -$0.97.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process